Ann: AGM Presentation, page-5

Nice day today, an ATH close and a Intraday ATH of 58c. Will pop up on more scans overnight and continue to accelerate on to radars. Free float diminishing quickly so price discovery is likely to take place on more parabolic moves, especially as stock is moved into sticky hands.

The presentation is of a high quality and well detailed. December is going to be very busy for us with multiple ARG-007 study results to be released. Of particular importance is the calibre of the BOD as well as the scientific team, with over 100 years of experience in neuroscience just within the research team, as well as authoring well over 50 peer reviewed scientific articles between them.

With the IP creators escrowing their shares for two years and the strong contingent of highly regarded folks from UWA and outside institutions, they must certainly be confident of the drug's prospects.

I think you're right on the raise Leferve, the company would be well served to look at that after indications of phase 1 safety, by which time the price should have popped up those levels on market reaction